Arkema SA (OTCMKTS:ARKAY – Get Free Report) has earned an average recommendation of “Reduce” from the six analysts that are presently covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and one has given a buy rating to the company.
A number of equities research analysts recently commented on the company. Barclays lowered Arkema from a “hold” rating to a “strong sell” rating in a research report on Tuesday, November 11th. Deutsche Bank Aktiengesellschaft downgraded shares of Arkema from a “buy” rating to a “hold” rating in a report on Monday, November 24th. Citigroup reissued a “buy” rating on shares of Arkema in a report on Friday, October 3rd. Finally, Zacks Research lowered shares of Arkema from a “hold” rating to a “strong sell” rating in a report on Tuesday.
Check Out Our Latest Stock Report on ARKAY
Arkema Price Performance
Arkema (OTCMKTS:ARKAY – Get Free Report) last posted its quarterly earnings results on Friday, November 7th. The basic materials company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.21. The business had revenue of $2.52 billion for the quarter, compared to the consensus estimate of $2.50 billion. Arkema had a return on equity of 5.15% and a net margin of 1.55%. As a group, equities research analysts forecast that Arkema will post 8.36 earnings per share for the current year.
About Arkema
Arkema SA is a global specialty chemicals and advanced materials company headquartered in Colombes, France. Established in 2004 as a spin-off from Total’s chemicals division, the company offers a broad portfolio of high-performance materials designed to improve durability, thermal and chemical resistance, and environmental performance across diverse industries.
Arkema’s operations are organized into four core segments. Adhesive Solutions delivers bonding, sealing, and coating technologies for markets such as packaging, medical devices, and consumer goods.
Featured Stories
- Five stocks we like better than Arkema
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- Do not delete, read immediately
- This stock gets a 94 out of 100
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- How the Rich Retire
Receive News & Ratings for Arkema Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arkema and related companies with MarketBeat.com's FREE daily email newsletter.
